SCHEMBL24413699

SCHEMBL24413699

Cc1cc(I)cc(I)c1Oc1ccc2cc(C(=O)O)ccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
THRA P10827 2/20 0.42
THRB P10828 2/20 0.42
GRIN2D O15399 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2C Q14957 1/20 0.40
RARA P10276 3/20 0.37
RARB P10826 3/20 0.37
RARG P13631 3/20 0.37
CYP26A1 O43174 1/20 0.37
CYP26B1 Q9NR63 1/20 0.37
HPGD P15428 3/20 0.36
CYP1A2 P05177 2/20 0.36
HSD17B10 Q99714 2/20 0.36
RXRA P19793 2/20 0.36
HTT P42858 1/20 0.36
ABCB11 O95342 1/20 0.36
LMNA P02545 1/20 0.36
PGR P06401 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24407698 0.89 RXRA (0.45) THRATHRBHPGDRXRAHTT
SCHEMBL24407809 0.85 AKR1C3 (0.54) KDM4ETHRATHRBPOLBAR
SCHEMBL24407686 0.82 THRB (0.44) THRATHRBGRIN2DGRIN2AGRIN2C
SCHEMBL24413704 0.81 KDM4E (0.58) KDM4ERARARARBRARGCYP26A1
SCHEMBL24407812 0.78 THRB (0.47) THRATHRBHPGDCYP1A2HSD17B10
SCHEMBL24413695 0.78 TPMT (0.50) THRATHRBHPGDCYP1A2HSD17B10
SCHEMBL24413696 0.76 KDM4E (0.59) KDM4ERXRAPOLBCYP2C9HIF1A
SCHEMBL8080613 0.74 KDM4E (0.69) KDM4EHPGDRXRAPOLBALDH1A1
SCHEMBL18545874 0.72 KDM4E (0.67) KDM4ERARARARBRARGCYP26A1
SCHEMBL9781486 0.72 KDM4E (0.67) KDM4ERXRAPOLBPDE4DCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, FGFR1, NHERF1 KDM4E 4412/4885THRA 660/4885THRB 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.